You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials

Article info

Article menu

Download PDFPDF

XML
Commentary
Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials

Authors

  • Jia-Wei Lv Department of Radiation OncologySun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy 651 Dongfeng Road East 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Jun-Yan Li Department of Radiation OncologySun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy 651 Dongfeng Road East 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Lin-Na Luo Department of Medical OncologySun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Zi-Xian Wang Department of Medical OncologySun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Yu-Pei Chen Department of Radiation OncologySun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy 651 Dongfeng Road East 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles

Citation

Lv J, Li J, Luo L, et al
Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials
Journal for ImmunoTherapy of Cancer 2019;7:159. doi: 10.1186/s40425-019-0636-7
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.